Concord Wealth Partners »

Stoke Therapeutics shares owned by Concord Wealth Partners

Quarter-by-quarter ownership of Stoke Therapeutics (STOK) shares owned by Concord Wealth Partners from 13F filings

Historical chart of Concord Wealth Partners investment in Stoke Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Stoke Therapeutics held by Concord Wealth Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Stoke Therapeutics by Concord Wealth Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $12k 500 23.50
2025-06-30 $5.7k 500 11.35